Advisory Services Network, LLC Gritstone Bio, Inc. Transaction History

Advisory Services Network, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.28 - $2.85 $870 - $1,938	680 New	680 $1,000
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $1,475 - $2,665	680 New	680 $2,000
Q3 2021 Nov 05, 2021	SELL	$6.41 - $13.54 $4,358 - $9,207	-680 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$8.13 - $10.2 $5,528 - $6,935	680 New	680 $6,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.